Key Growth Benchmarks for US Industries

Nifty Financial Providers 25/50 HDFCBank, ICICI BANK, AxisB, PFC, SBIN, REC Ltd, Shriram Fin, BajFinance, Kotakbank, Bajfinsv, SBILife, HDFCLife, Cholafin, ICICIGI, HDFC AMC, ICICIPruli, SBICARD, Lichsgfin, Muthootfin, IDFC. (Overall 20)5. Clever FMCGITC, Hindunilvr, Nestleind, VBL, Tataconsum, Britannia, Godrejcp, Colpal, Dabur, United spirit, Marico, PGHH, UBL, Radico, Balramchi. (Overall 15)6. Clever HealthcareSunpharma, Cipla, Dr reddy, Apollo Hosp, Max health, Divislab, Lupin, Auropharma, Zydus Life, Torntpharm, Alkem, Glenmark, Laurus Lab, Ipcalab, Biocon, Abbotindia, Syngene, Lalpathlab, granules, City.

Online Website Marketing

(Total 10)8. Clever MediaZEEL, PVRNOX, Suntv, Saregama, TV18Brdcst, Nazara, Dishtv, Network18, Tipsindltd, Hathway. (Overall 10) 9. Clever MetalTatasteel, Hindalco, Adanient, JSWsteel, VEDL, Jindalstel, NMDC, Aplapollo, JSL, SAIL, Hindzinc, Nationalum, Hindcoppr, Ratnamani, Welcorp. (Overall 15)10. Nifty PharmaSunpharma, Cipla, Dr reddy, Divislab, Lupin, Auropharma, Auropharma, Zyduslife, Alkem, Glenmark, Humanity, Lauruslabs, IPCAlab, Abbotindia, Biocon, Gland, Sanofi, JBchempharm, Narcopharm, granules.

(Total 10)12. Clever PSU BankSBIN, BankBaroda, Canbk, PNB, UnionBk, IndianB, BankIndia, MahaBk, IOB, Reserve Bank, UCO bank, PSB13.Nifty EnergyReliance, NTPC, Powergrid, Coal india, ONGC, Tatapower, Adani green energy, BPCL, IOC, Adani Energy (Total 10) 14. Nifty RealityDLF, Lodha, GodrejProp, Phoenixltd, Status, Oberoirlty, Brigade, Sobha, Mahlife, Sunteck (Overall 10)15. Clever Customer DurablesTitan, Havells, Dixon, Voltas, Crompton, Bluestarco, Kajariacer, Kalyanijil, Vguard, Whirlpool, Cera, Rajeshexpo, Centuryply (Total 13)16. Nifty Oil and GasReliance, ONGC, IOC, GAIL, BPCL, ATGL, Hindpetro, IGL, GSPL, Castrolind, Gujgasltd, Aegischem.

Online Website Marketing

The infotech sector continues to see strong demand and development in India, with IT stocks regularly outshining the broader market. Health care and pharmaceuticals is another sector that has actually seen increased financial investment and focus, as India intends to improve access to quality healthcare and end up being a global hub for generic drug production.